Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Moore

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
The Journal of Infectious Diseases|May 13, 2009
Rethinking replacement and resistanceMatthew R Moore
Cognitive, Affective & Behavioral Neuroscience|November 6, 2016
Mu rhythm suppression is associated with the classification of emotion in facesMatthew R Moore, Elizabeth A Franz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect?Matthew R Moore, Cynthia G Whitney
Emerging Infectious Diseases|August 21, 2015
Use of Pneumococcal Disease Epidemiology to Set Policy and Prevent Disease during 20 Years of the Emerging Infections ProgramMatthew R Moore, Cynthia G Whitney
Social Work in Health Care|January 15, 2015
Medication adherence skills training for African-American breast cancer survivors: the effects on health literacy, medication adherence, and self-efficacyConnie F Rust, Cindy Davis, Matthew R Moore
The Lancet. Infectious Diseases|April 8, 2003
Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsisMatthew R Moore, Stephanie J Schrag, Anne Schuchat
Vaccine|April 16, 2013
Forecasting invasive pneumococcal disease trends after the introduction of 13-valent pneumococcal conjugate vaccine in the United States, 2010-2020Ruth Link-Gelles, Thomas Taylor, Matthew R Moore, et al.
Vaccine|August 22, 2012
7-Valent pneumococcal conjugate vaccine and otitis media: effectiveness of a 2-dose versus 3-dose primary seriesCharles Stoecker, Lee M Hampton, Matthew R Moore
Frontiers in Human Neuroscience|February 26, 2019
Mental Simulation of Facial Expressions: Mu Suppression to the Viewing of Dynamic Neutral Face VideosOzge Karakale, Matthew R Moore, Ian J Kirk
The Lancet. Infectious Diseases|May 31, 2011
Assessing the effect of pneumococcal conjugate vaccines: what is the value of routinely collected surveillance data?Carlos G Grijalva, Matthew R Moore, Marie R Griffin
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Infectious Diseases|May 13, 2009
Rethinking replacement and resistanceMatthew R Moore
Cognitive, Affective & Behavioral Neuroscience|November 6, 2016
Mu rhythm suppression is associated with the classification of emotion in facesMatthew R Moore, Elizabeth A Franz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect?Matthew R Moore, Cynthia G Whitney
Emerging Infectious Diseases|August 21, 2015
Use of Pneumococcal Disease Epidemiology to Set Policy and Prevent Disease during 20 Years of the Emerging Infections ProgramMatthew R Moore, Cynthia G Whitney
Social Work in Health Care|January 15, 2015
Medication adherence skills training for African-American breast cancer survivors: the effects on health literacy, medication adherence, and self-efficacyConnie F Rust, Cindy Davis, Matthew R Moore
The Lancet. Infectious Diseases|April 8, 2003
Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsisMatthew R Moore, Stephanie J Schrag, Anne Schuchat
Vaccine|April 16, 2013
Forecasting invasive pneumococcal disease trends after the introduction of 13-valent pneumococcal conjugate vaccine in the United States, 2010-2020Ruth Link-Gelles, Thomas Taylor, Matthew R Moore, et al.
Vaccine|August 22, 2012
7-Valent pneumococcal conjugate vaccine and otitis media: effectiveness of a 2-dose versus 3-dose primary seriesCharles Stoecker, Lee M Hampton, Matthew R Moore
Frontiers in Human Neuroscience|February 26, 2019
Mental Simulation of Facial Expressions: Mu Suppression to the Viewing of Dynamic Neutral Face VideosOzge Karakale, Matthew R Moore, Ian J Kirk
The Lancet. Infectious Diseases|May 31, 2011
Assessing the effect of pneumococcal conjugate vaccines: what is the value of routinely collected surveillance data?Carlos G Grijalva, Matthew R Moore, Marie R Griffin
Pageof 11